Oliver Luxxe Assets LLC Invests $1.47 Million in Ardent Health Partners, LLC (NYSE:ARDT)

Oliver Luxxe Assets LLC bought a new position in shares of Ardent Health Partners, LLC (NYSE:ARDT - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 85,754 shares of the company's stock, valued at approximately $1,465,000. Oliver Luxxe Assets LLC owned approximately 0.06% of Ardent Health Partners as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. State Street Corp bought a new stake in shares of Ardent Health Partners during the 3rd quarter worth $1,977,000. Allspring Global Investments Holdings LLC purchased a new stake in Ardent Health Partners during the third quarter valued at about $13,119,000. Goldentree Asset Management LP bought a new stake in Ardent Health Partners during the third quarter worth about $22,897,000. Jane Street Group LLC purchased a new position in shares of Ardent Health Partners in the 3rd quarter worth about $567,000. Finally, Franklin Resources Inc. bought a new position in shares of Ardent Health Partners during the 3rd quarter valued at about $15,839,000.

Analysts Set New Price Targets

ARDT has been the subject of several research reports. Bank of America lowered Ardent Health Partners from a "buy" rating to a "neutral" rating and cut their target price for the stock from $22.00 to $19.00 in a research note on Wednesday, November 6th. Leerink Partners increased their target price on shares of Ardent Health Partners from $23.00 to $25.00 and gave the company an "outperform" rating in a report on Tuesday, November 12th. KeyCorp assumed coverage on shares of Ardent Health Partners in a research note on Friday, October 11th. They issued an "overweight" rating and a $24.00 price target for the company. JPMorgan Chase & Co. reaffirmed a "neutral" rating and set a $20.00 price objective on shares of Ardent Health Partners in a research note on Tuesday, December 17th. Finally, Truist Financial lowered their target price on Ardent Health Partners from $22.00 to $21.00 and set a "buy" rating for the company in a research note on Monday. Two equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Buy" and an average target price of $22.00.

Ardent Health Partners Trading Up 2.7 %

Shares of NYSE:ARDT traded up $0.43 on Tuesday, hitting $16.35. The company had a trading volume of 178,645 shares, compared to its average volume of 269,561. Ardent Health Partners, LLC has a 1 year low of $14.57 and a 1 year high of $20.72. The company has a current ratio of 1.91, a quick ratio of 1.78 and a debt-to-equity ratio of 0.78. The stock's 50-day moving average is $16.71.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.